A large randomized controlled trial found that a prescription medication derived from the active compound in cannabis significantly reduced the frequency of nightmares in adults with post-traumatic stress disorder. More than a third of participants who took the medication saw their nightmares stop entirely after ten weeks of treatment.

What the Research Found

In a double-blind, placebo-controlled trial, adults with PTSD and recurring nightmares were randomly assigned to take either a THC-based medication or a placebo each night before bed for ten weeks. Nearly 58 percent of those taking the medication saw their nightmares cut by at least half, compared to about 29 percent of those on placebo. More than a third of the treatment group reported that their nightmares disappeared completely by the end of the trial. Researchers believe the compound may reduce dream activity during a stage of sleep linked to trauma-related nightmares, potentially lowering the nighttime stress response tied to traumatic memories.

Why It Matters

Nightmares are among the most persistent and distressing symptoms of PTSD, often driving sleep avoidance, exhaustion, and reduced quality of life, and they frequently persist even after other PTSD symptoms improve with standard treatment. Options specifically targeting nightmares have been limited, so a treatment showing this level of benefit in a rigorous trial is notable.

Symptoms

PTSD-related nightmares typically involve vivid re-experiencing of traumatic events during sleep, waking in distress or panic, sweating, a racing heart, and difficulty falling back asleep. Over time, this can lead to sleep avoidance, chronic fatigue, irritability, and worsening of other PTSD symptoms during the day.

When to Seek Help

If nightmares are frequent, distressing, disrupting sleep, or connected to a past traumatic experience, it is worth discussing with a healthcare provider, particularly if they are affecting daytime functioning, mood, or safety.

How to Talk to Your Doctor About This

Describe how often the nightmares occur, their content or themes if relevant, how they affect your sleep and next-day functioning, and any current PTSD treatments or medications. Ask whether newer nightmare-focused treatments, including this type of medication, might be appropriate for your situation.

Which Professional to See

A psychiatrist experienced in treating PTSD is generally best positioned to evaluate nightmare-focused treatment options, including medication. A sleep specialist or a therapist trained in trauma-focused therapies can also help address nightmares as part of a broader treatment plan.

Questions to Ask

• Could a nightmare-focused treatment help alongside my current PTSD care?
• What are the potential side effects or risks of this type of medication?
• How long would treatment need to continue before we know if it is working?
• Are there non-medication options that address nightmares as effectively?

What This Research Does Not Prove

This trial focused specifically on nightmare frequency over ten weeks and does not establish long-term safety, dependency risk, or effectiveness beyond that window. It does not show that this medication improves other PTSD symptoms, and it should not be assumed to be a substitute for trauma-focused therapy or established first-line treatments. Access to this type of medication also varies by country and regulatory status.

Bottom Line

This trial offers encouraging evidence for a targeted treatment for one of the most disruptive symptoms of PTSD, though longer-term studies and broader clinical experience will be needed before it becomes a standard option.

Related Topics

Related reading: Post-Traumatic Stress Disorder